We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 261

General Court examines the introduction of new pleas in law during the course of proceedings before the court
  • Hogan Lovells
  • European Union
  • January 28 2015

On 22 January 2015, the Sixth Chamber of the General Court of the Court of Justice of the European Union (“General Court”) issued its judgement in


EMA adopts new guideline on modified release dosage forms
  • Hogan Lovells
  • European Union
  • December 5 2014

On 27 November 2014, the European Medicines Agency (“EMA”) published its new guideline on the pharmacokinetic and clinical evaluation of modified


European Commission Action Plan on Antimicrobial Resistance
  • Hogan Lovells
  • European Union
  • March 3 2015

On 26 February 2015, the European Commission published a progress report concerning the Commission's five year Action Plan on Antimicrobial


EU, UK: CJEU opinion delivered on the Specific Mechanism
  • Hogan Lovells
  • United Kingdom, European Union
  • October 23 2014

Advocate General Niilo Jääskinen’s opinion on the interpretation of the Specific Mechanism (in the case of Merck v Sigma (Case C-53913) was


EU: relatively high level of attention in the field of pharmaceutical products
  • Hogan Lovells
  • European Union
  • October 23 2014

Once more the General Court has confirmed that the relevant public in the field of pharmaceutical products - consisting both of medical professionals


EMA begins publishing the outcome of safety reports concerning nationally authorised medicinal products
  • Hogan Lovells
  • European Union
  • July 20 2015

On 6 July 2015, the European Medicines Agency ("EMA") announced that it would begin publishing the outcome of single assessments of period safety


EU orphan drug exclusivity
  • Hogan Lovells
  • European Union
  • January 26 2015

On 22 January 2015, the General Court of the Court of Justice of the European Union issued its judgment in the case between Teva and the European


European Commission pharmaceutical sector inquiry Final Report drug problems remain but Commission softens its stance
  • Hogan Lovells
  • European Union
  • July 30 2009

On July 8, 2009 the European Commission (EC) published its long-awaited final report on its inquiry into the pharmaceutical sector (Final Report


Advocate General’s opinion in GlaxoSmithKline: still no legal certainty for the pharmaceutical industry regarding parallel trade
  • Hogan Lovells
  • European Union
  • July 30 2009

On June 30, 2009, EU Advocate General (AG) Trstenjak gave her opinion in the GlaxoSmithKline (GSK) case regarding restrictions of parallel trade before the European Court of Justice (ECJ


French legal and regulatory update - April 2014
  • Hogan Lovells
  • European Union, France
  • May 1 2014

Draft law granting amnesty for acts committed in the course of social movements and trade unions' protesting activities Filed on November 28, 2012